康惠股份追讨2.66亿元业绩补偿款,海思科1类新药获批临床,恒瑞医药二代AR抑制剂新进展,智云健康与京东健康签订服务合作协议

谈医说药
Nov 13, 2025

长春高新:公司子公司长春金赛药业有限责任公司收到美国食品药品监督管理局书面通知,金赛药业注射用GenSci143临床试验申请获得批准。GenSci143是金赛药业自主研发的一款靶向B7-H3与PSMA的双特异性抗体偶联药物(BsADC),具有靶向化疗和肿瘤免疫双重潜在治疗作用。是一款治疗用生物制品1类药物,拟用于前列腺癌、肺癌等多种晚期实体肿瘤治疗。甘李药业:公司自主研发的甘精胰岛素注射液(欧盟...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10